The relationship between midlife dietary habits and risk of dementia remains unclear.
Objective:
To investigate the association between dietary fish and n-3 polyunsaturated fatty acid (PUFA) consumption in midlife and risk of dementia in later life.
Methods:
This population-based cohort study assessed food frequency (average intake in 1995 and 2000) and cognition (2014-2015) in 1,127 participants (aged 45–64 in 1995). We used logistic regression analyses to calculate odds ratios (ORs) for dementia and mild cognitive impairment (MCI) diagnoses for consumption quartiles of fish, PUFA-rich fish, total n-3 PUFAs, total n-6 PUFAs, types of PUFAs, and n-3/n-6 PUFA ratio. Estimated ORs were adjusted for age; sex; education; smoking status; alcohol consumption frequency; physical activity; histories of cancer, myocardial infarction, and diabetes mellitus; and depression.
Results:
Significantly reduced risks of dementia over non-dementia (MCI plus cognitively normal) were observed in the second (OR = 0.43 (95% CI = 0.20–0.93)), third (OR = 0.22 (95% CI = 0.09–0.54)), and highest quartiles (OR = 0.39 (95% CI = 0.18–0.86)) for fish; the third (OR = 0.39 (95% CI = 0.16–0.92)) and highest quartiles (OR = 0.44 (95% CI = 0.19–0.98)) for eicosapentaenoic acid (EPA); the second (OR = 0.39 (95% CI = 0.18–0.84)), third (OR = 0.30 (95% CI = 0.13–0.70)), and highest quartiles (OR = 0.28 (95% CI = 0.12–0.66)) for docosahexaenoic acid (DHA); and the third (OR = 0.36 (95% CI = 0.16–0.85)) and highest quartiles (OR = 0.42 (95% CI = 0.19–0.95)) for docosapentaenoic acid (DPA).
Conclusion:
High intake of fish in midlife might aid in preventing dementia.
ZengLF, CaoY, LiangWX, BaoWH, PanJK, WangQ, LiuJ, LiangHD, XieH, ChaiYT, GuanZT, CaoQ, LiXY, YangL, XuWH, MiSQ, WangNS (2017) An exploration of the role of a fish-oriented diet in cognitive decline: A systematic review of the literature. Oncotarget8, 39877–39895.
2.
ZhangY, ChenJ, QiuJ, LiY, WangJ, JiaoJ (2016) Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. Am J Clin Nutr103, 330–340.
3.
WuS, DingY, WuF, LiR, HouJ, MaoP (2015) Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: A meta-analysis. Neurosci Biobehav Rev48, 1–9.
4.
CederholmT (2017) Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer’s disease in older adults - any news?Curr Opin Clin Nutr Metab Care20, 104–109.
5.
IsoH, SatoS, FolsomAR, ShimamotoT, TeraoA, MungerRG, KitamuraA, KonishiM, IidaM, KomachiY (1989) Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol18, 374–381.
6.
DyallSC (2015) Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci7, 52.
7.
SamieriC, FeartC, LetenneurL, DartiguesJF, PeresK, AuriacombeS, PeuchantE, DelcourtC, Barberger-GateauP (2008) Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr88, 714–721.
8.
RobertsRO, CerhanJR, GedaYE, KnopmanDS, ChaRH, ChristiansonTJ, PankratzVS, IvnikRJ, O’ConnorHM, PetersenRC (2010) Polyunsaturated fatty acids and reduced odds of MCI: The Mayo Clinic Study of Aging. J Alzheimers Dis21, 853–865.
9.
ChanR, ChanD, WooJ (2013) A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong. J Nutr Health Aging17, 757–765.
10.
TsuganeS, SawadaN (2014) The JPHC study: Design and some findings on the typical Japanese diet. Jpn J Clin Oncol44, 777–782.
11.
Ardisson KoratAV, LiY, SacksF, RosnerB, WillettWC, HuFB, SunQ (2019) Dairy fat intake and risk of type 2 diabetes in 3 cohorts of US men and women. Am J Clin Nutr110, 1192–1200.
12.
TsubonoY, TakahashiT, IwaseY, IitoiY, AkabaneM, TsuganeS (1997) Nutrient consumption and gastric cancer mortality in five regions of Japan. Nutr Cancer27, 310–315.
13.
HidakaA, ShimazuT, SawadaN, YamajiT, IwasakiM, SasazukiS, InoueM, TsuganeS (2015) Fish, n-3 PUFA consumption, and pancreatic cancer risk in Japanese: A large, population-based, prospective cohort study. Am J Clin Nutr102, 1490–1497.
14.
Science and Technology Agency (1990) Fatty acids, cholesterol, vitamin E composition tables of Japanese foods (in Japanese). Ichiyaku Shuppan, Tokyo.
15.
The Council for Science and Technology, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (2010).
16.
WillettW, StampferMJ (1986) Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol124, 17–27.
17.
NanriA, ShimazuT, IshiharaJ, TakachiR, MizoueT, InoueM, TsuganeS (2012) Reproducibility and validity of dietary patterns assessed by a food frequency questionnaire used in the 5-year follow-up survey of the Japan Public Health Center-Based Prospective Study. J Epidemiol22, 205–215.
18.
KobayashiM, SasakiS, KawabataT, HasegawaK, TsuganeS, Jphc (2003) Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: Comparison with dietary records and serum phospholipid level. J Epidemiol13, S64–81.
19.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
20.
ElwoodRW (1991) The Wechsler Memory Scale-Revised: Psychometric characteristics and clinical application. Neuropsychol Rev2, 179–201.
21.
AgrellB, DehlinO (1998) The clock-drawing test. Age Ageing27, 399–403.
22.
HughesCP, BergL, DanzigerWL, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
23.
RadloffLS (1977) The CES-D Scale:A Self-Report Depression Scale for Research in the General Population. Appl Psychol Meas1, 385–401.
24.
KroenkeK, SpitzerRL, WilliamsJB (2001) The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med16, 606–613.
25.
FujishimaM, KawaguchiA, MaikusaN, KuwanoR, IwatsuboT, MatsudaH, Japanese Alzheimer’s Disease Neuroimaging Initiative, Japanese Alzheimer’s Disease Neuroimaging Initiative (2017) Sample size estimation for Alzheimer’s disease trials from Japanese ADNI serial magnetic resonance imaging. J Alzheimers Dis56, 75–88.
26.
IwatsuboT (2010) Japanese Alzheimer’s Disease Neuroimaging Initiative: Present status and future. Alzheimers Dement6, 297–299.
ZhongG, WangY, ZhangY, GuoJJ, ZhaoY (2015) Smoking is associated with an increased risk of dementia: A meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One10, e0118333.
29.
XuW, WangH, WanY, TanC, LiJ, TanL, YuJT (2017) Alcohol consumption and dementia risk: A dose-response meta-analysis of prospective studies. Eur J Epidemiol32, 31–42.
30.
GuureCB, IbrahimNA, AdamMB, SaidSM (2017) Impact of physical activity on cognitive decline, dementia, and its subtypes: Meta-analysis of prospective studies. Biomed Res Int2017, 9016924.
31.
RoeCM, FitzpatrickAL, XiongC, SiehW, KullerL, MillerJP, WilliamsMM, KopanR, BehrensMI, MorrisJC (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology74, 106–112.
32.
DeckersK, SchievinkSHJ, RodriquezMMF, van OostenbruggeRJ, van BoxtelMPJ, VerheyFRJ, KohlerS (2017) Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis. PLoS One12, e0184244.
33.
KopfD, FrolichL (2009) Risk of incident Alzheimer’s disease in diabetic patients: A systematic review of prospective trials. J Alzheimers Dis16, 677–685.
34.
DevoreEE, GrodsteinF, van RooijFJ, HofmanA, RosnerB, StampferMJ, WittemanJC, BretelerMM (2009) Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr90, 170–176.
35.
KalmijnS, LaunerLJ, OttA, WittemanJC, HofmanA, BretelerMM (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol42, 776–782.
36.
NgabiranoL, SamieriC, FeartC, GabelleA, ArteroS, DuflosC, BerrC, MuraT (2019) Intake of meat, fish, fruits, and vegetables and long-term risk of dementia and Alzheimer’s disease. J Alzheimers Dis68, 711–722.
37.
LaitinenMH, NganduT, RovioS, HelkalaEL, UusitaloU, ViitanenM, NissinenA, TuomilehtoJ, SoininenH, KivipeltoM (2006) Fat intake at midlife and risk of dementia and Alzheimer’s disease: A population-based study. Dement Geriatr Cogn Disord22, 99–107.
38.
HiraiK, HoriuchiR, OhnoY, HiguchiH, AsanoY (2000) Lower eicosapentaenoic acid and higher arachidonic acid levels in Sera of young adults in the Netherlands than in Japan. Environ Health Prev Med5, 60–65.
39.
MorrisMC, EvansDA, TangneyCC, BieniasJL, WilsonRS (2005) Fish consumption and cognitive decline with age in a large community study. Arch Neurol62, 1849–1853.
40.
PanzaF, D’IntronoA, ColaciccoAM, CapursoC, Del ParigiA, CaselliRJ, PilottoA, ArgentieriG, ScapicchioPL, ScafatoE, CapursoA, SolfrizziV (2005) Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry13, 633–644.
41.
MarcosG, SantabarbaraJ, Lopez-AntonR, De-la-CamaraC, Gracia-GarciaP, LoboE, PirezG, MenchonJM, PalomoT, StephanBC, BrayneC, LoboA, ZARADEMP Workgroup (2016) Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen’s criteria. Acta Psychiatr Scand133, 378–385.
42.
YinY, FanY, LinF, XuY, ZhangJ (2015) Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: A cross-sectional study. J Nutr Health Aging19, 39–47.
43.
ThomasKR, EppigJS, WeigandAJ, EdmondsEC, WongCG, JakAJ, Delano-WoodL, GalaskoDR, SalmonDP, EdlandSD, BondiMW, Alzheimer’s Disease Neuroimaging Initiative (2019) Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Dement15, 561–569.
44.
KalmijnS, van BoxtelMP, OckeM, VerschurenWM, KromhoutD, LaunerLJ (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology62, 275–280.
45.
SchaeferEJ, BongardV, BeiserAS, Lamon-FavaS, RobinsSJ, AuR, TuckerKL, KyleDJ, WilsonPW, WolfPA (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol63, 1545–1550.
46.
SydenhamE, DangourAD, LimWS (2012) Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev, CD005379.
47.
Yurko-MauroK, McCarthyD, RomD, NelsonEB, RyanAS, BlackwellA, SalemNJr., StedmanM, InvestigatorsM (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement6, 456–464.
48.
MazereeuwG, LanctotKL, ChauSA, SwardfagerW, HerrmannN (2012) Effects of omega-3 fatty acids on cognitive performance: A meta-analysis. Neurobiol Aging33, 1482 e1417–1429.
49.
Yurko-MauroK, AlexanderDD, Van ElswykME (2015) Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLoS One10, e0120391.
50.
ShahidiF, AmbigaipalanP (2018) Omega-3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol9, 345–381.
51.
KiddPM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev12, 207–227.
52.
JanssenCI, KiliaanAJ (2014) Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res53, 1–17.
53.
MatsuokaYJ, SawadaN, MimuraM, ShikimotoR, NozakiS, HamazakiK, UchitomiY, TsuganeS (2017) Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: A population-based prospective cohort study. Transl Psychiatry7, e1242.
54.
MartinsJG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: Evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr28, 525–542.
CheH, ZhouM, ZhangT, ZhangL, DingL, YanagitaT, XuJ, XueC, WangY (2018) Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer’s disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice. Food Funct9, 643–654.
IkemotoA, OhishiM, SatoY, HataN, MisawaY, FujiiY, OkuyamaH (2001) Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: Level of n-6 fatty acids as another critical factor. J Lipid Res42, 1655–1663.
59.
ContrerasMA, RapoportSI (2002) Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr Opin Lipidol13, 267–272.
60.
HuangTL, ZandiPP, TuckerKL, FitzpatrickAL, KullerLH, FriedLP, BurkeGL, CarlsonMC (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology65, 1409–1414.
61.
RizziL, RossetI, Roriz-CruzM (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int2014, 908915.
62.
AlexanderM, PereraG, FordL, ArrighiHM, FoskettN, DeboveC, NovakG, GordonMF (2015) Age-stratified prevalence of mild cognitive impairment and dementia in european populations: A systematic review. J Alzheimers Dis48, 355–359.
63.
WardA, ArrighiHM, MichelsS, CedarbaumJM (2012) Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement8, 14–21.
64.
van de RestO, BerendsenAA, Haveman-NiesA, de GrootLC (2015) Dietary patterns, cognitive decline, and dementia: A systematic review. Adv Nutr6, 154–168.
